Julie M Vose, MD, MBA

Julie M. Vose, MD, MBA
Professor, Internal Medicine, Division Chiefvose2
Division of Oncology & Hematology

Academic Office mailing address:
UNMC Oncology/Hematology Division
986840 Nebraska Medical Center
Omaha, NE 681980-6840

Main Academic Ph. 402-559-8500
New Patient Referral Ph. 402-559-5600
Fax. 402-559-6520

Practice locations:
Fred & Pamela Buffett Cancer Center
505 South 45th Street
Omaha, NE 68105 (map)

Nebraska Medicine Village Pointe
111 North 175th Street
Omaha, NE 68118 (map)

Education:
University of Colorado, MBA (2011)
University of Nebraska Medical Center, Resident, (1987)
University of Nebraska Medical Center, Chief Resident, (1988)
University of Nebraska Medical Center, Fellow, (1990)
South Dakota State University, BS, (1978)
University of Nebraska Medical Center, BS MT (ASCP), (1979)
University of Nebraska Medical Center, MD, (1984)

Hospital Appointments:
Nebraska Medicine

Interests:
Research in novel therapies for Hodgkin disease, non-Hodgkin lymphoma, Multiple Myeloma, CLL

Biographical Sketch:

Dr Julie M. Vose is the Neumann M. and Mildred E. Harris Professor and the Chief of the Division of Oncology/Hematology in the Department of Internal Medicine at UNMC. Dr Vose graduated from Medical School at UNMC, completed her Internal Medicine Residency as well as a Chief Resident year, followed by a Hematology/Oncology Fellowship at UNMC, and has been on faculty since 1990.  She also completed an MBA in Health Administration through the University of Colorado Business School. Dr Vose is an internationally known leading expert in the treatment of patients with Hodgkin lymphoma, non-Hodgkin lymphoma, and Chronic Lymphocytic Leukemia. Dr Vose is actively involved in many novel clinical trials for lymphoma including targeted agents, monoclonal antibodies, and cellular therapy.  Dr. Vose has published over 400 articles in high profile medical journals, most of which deal with finding optimum care and treatment for patients with lymphoma. She has also been active with national and international Hematology/Oncology Societies and served as the 2016 President of the American Society of Clinical Oncology (ASCO).

 

Publications at PubMed.Gov: https://pubmed.ncbi.nlm.nih.gov/?term=Vose+JM&sort=date